Clinic
Southwestern Vermont Medical Center INC.
Southwestern Vermont Medical Center INC. was paid $5.13M by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoSOUTHWESTERN VERMONT MEDICAL CENTER INC.
BENNINGTON, VT 05201
BENNINGTON, VT 05201
33aNPI1205865789assigned 06/30/2006
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$5.13M
24GClaims150,798
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Vermont
Rank by total paid#1 of 5
Median peer was paid$225K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,854 | $466K | |
| 2019 | 19,331 | $499K | |
| 2020 | 19,402 | $667K | |
| 2021 | 29,647 | $1.11M | |
| 2022 | 27,147 | $1.01M | |
| 2023 | 23,222 | $784K | |
| 2024incomplete | 15,195 | $589K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 21,074 | 18,292 | $1.16M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 24,168 | 21,446 | $979K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.1% | 6,373 | 4,754 | $413K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.9% | 4,851 | 4,229 | $354K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.4% | 15,576 | 12,946 | $278K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 1,091 | 987 | $258K |
| 80053 | Comprehensive metabolic panel | 2.7% | 6,229 | 5,496 | $137K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 1,722 | 1,580 | $128K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.2% | 4,619 | 4,424 | $112K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.0% | 2,212 | 2,139 | $104K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.9% | 5,421 | 3,935 | $97K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 877 | 842 | $85K |
78 more codes
| 36415 | Collection of venous blood by venipuncture | 1.6% | 4,324 | $82K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 6,796 | $77K |
| 84703 | 1.4% | 1,194 | $71K | |
| 84484 | 1.3% | 799 | $68K | |
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 920 | $59K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.1% | 18,653 | $55K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,924 | $40K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 138 | $40K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 647 | $35K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 652 | $32K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,452 | $28K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 653 | $27K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 114 | $27K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,246 | $23K |
| 80061 | Lipid panel | <1% | 674 | $20K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 566 | $20K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 81 | $20K |
| 99223 | Prolong inpt eval add15 m | <1% | 343 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 659 | $17K |
| 87081 | <1% | 673 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 513 | $17K |
| 81003 | <1% | 1,127 | $16K | |
| 71045 | Radiologic examination, chest; single view | <1% | 356 | $16K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 492 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 180 | $12K |
| 87070 | <1% | 345 | $12K | |
| 73610 | <1% | 71 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 112 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 193 | $9K |
| 81001 | <1% | 1,178 | $9K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 50 | $9K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 355 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 148 | $9K |
| 80306 | <1% | 101 | $9K | |
| 84439 | <1% | 310 | $8K | |
| 88141 | <1% | 642 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 123 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 175 | $7K |
| 82947 | <1% | 82 | $7K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 164 | $6K |
| 86618 | <1% | 237 | $4K | |
| 87205 | <1% | 203 | $4K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 138 | $3K |
| 83690 | <1% | 1,037 | $3K | |
| 0012A | <1% | 37 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 99 | $2K |
| 87186 | <1% | 87 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 50 | $1K |
| 94010 | <1% | 511 | $1K | |
| 81000 | <1% | 102 | $1K | |
| 86803 | <1% | 50 | $1K | |
| 0011A | <1% | 36 | $938.86 | |
| 83655 | <1% | 43 | $871.10 | |
| 85652 | <1% | 81 | $843.64 | |
| 99462 | <1% | 30 | $740.92 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 25 | $497.60 |
| 87468 | <1% | 12 | $444.65 | |
| 87469 | <1% | 12 | $425.32 | |
| 87484 | <1% | 12 | $425.32 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 16 | $335.40 |
| 82570 | <1% | 38 | $325.69 | |
| J3490 | Unclassified drugs | <1% | 152 | $308.47 |
| 83735 | <1% | 28 | $306.57 | |
| 85027 | <1% | 13 | $156.86 | |
| 82077 | <1% | 15 | $111.87 | |
| 82043 | <1% | 12 | $107.32 | |
| 85610 | <1% | 18 | $102.30 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 864 | $73.54 |
| 88304 | <1% | 13 | $44.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 298 | $43.76 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 13 | $21.65 |
| 51798 | <1% | 15 | $11.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 636 | $11.38 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 194 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 121 | $0.00 |
| 90686 | 0% | 31 | $0.00 | |
| 91301 | 0% | 69 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEE, THOMAS (CEO)
| Provider | Location | Paid |
|---|---|---|
| Southwestern Vermont Medical Center INC. | Bennington, VT | $2.86M |
| Southwestern Vermont Medical Center, INC | Bennington, VT | $664K |
| Southwestern Vermont Medical Center, INC | Bennington, VT | $77K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.